{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-22-000009","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2022-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.130529+00:00","generated_at":"2026-06-27T05:59:33.890920+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Emergent BioSolutions: Executive Chairman retiring Apr 1; bonuses at 75% of target; Saran, Fox promoted","bullets":["Fuad El-Hibri to retire as Executive Chairman effective April 1, 2022; no 2022 equity grant.","2021 cash bonuses paid at ~75% of target due to below-target performance; CEO Kramer received $900,000.","Atul Saran promoted to EVP, Chief Strategy and Development Officer effective March 1, 2022.","Jennifer Fox promoted to EVP, External Affairs, General Counsel and Corporate Secretary effective March 1, 2022.","One-time retention equity awards granted to NEOs (excluding El-Hibri); Kramer got $900K in PSUs."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-22-000009","json":"https://secwatch.observer/filing/0001367644-22-000009.json","markdown":"https://secwatch.observer/filing/0001367644-22-000009.md","text":"https://secwatch.observer/filing/0001367644-22-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000009/0001367644-22-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000009/ebs-20220215.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:59:33.890920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dd2b324a29","claim":"Fuad El-Hibri departed as Executive Chairman at Emergent BioSolutions Inc..","evidence_excerpt":"The Executive Chairman, who has announced that he will retire from the Company effective April 1, 2022, will not receive an annual equity grant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000009/0001367644-22-000009-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}